Hexarelin is a synthetic growth hormone secretagogue belonging to the group of growth hormone-releasing peptides. It interacts with receptors involved in stimulating pituitary growth hormone secretion.
Research has examined Hexarelin’s effects on growth hormone release, cardiovascular signaling, and other endocrine processes. Its activity is distinct from direct administration of recombinant human growth hormone because it stimulates endogenous secretion.
Hexarelin is primarily associated with experimental research rather than established routine medical treatment. Changes in growth hormone and IGF-1 levels can have broader metabolic effects.
Reviews
There are no reviews yet.